Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab

• Status: Completed
• Trial end date: 2012-12-01

Summary

This is a multicentre, open labeled, controlled phase study designed to assess effectiveness of chemoembolization with LC Beads, both with and without systemic chemotherapy, in the treatment of unresectable liver metastases in patients with colorectal cancer.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: University of Louisville
• Collaborator: Biocompatibles UK Ltd
• Treatments: Bevacizumab; Camptothecin; Fluorouracil; Irinotecan; Leucovorin; Oxaliplatin